BioShares Biotech Clinical Trials Fund, Up 5%, Is Today’s Top Performing ETF

biotech-white-pills
The BioShares Biotechnology Clinical Trials Fund (BBC) outperformed all other non-leveraged, non-inverse exchange traded products in the U.S. today on a percentage basis, producing a +5.03% one-day return and outperforming the wider markets by a total of 5.04 percentage points.
NASDAQ:BBC January 31, 2017 5:42pm

BioShares Launches Two New Biotechnology ETFs

etfsLifeSci Index Partners, LLC (“LSIP”), a New York City-based investment advisor and index provider, today launched the BioShares™ Biotechnology Clinical Trials Fund (NASDAQ:BBC) and the BioShares™ Biotechnology Products Fund (NASDAQ:BBP) (together, “the Funds”). 
NASDAQ:BBC December 17, 2014 2:07pm

Recommended for You

Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories